| |
| |
|
| Insider
Information: |
Ricks David A |
| Relationship: |
Director |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
481,225 |
|
|
Indirect Shares
|
144,309 |
|
|
| Direct
Value |
$378,137,901 |
|
|
|
Indirect Value
|
$112,164,667 |
|
|
| Total
Shares |
625,534 |
|
|
| Total
Value |
$490,302,568 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 75.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
President, Chair, and ... |
2024-02-12 |
479,250 |
2024-02-12 |
139,637 |
Premium* |
|
|
Adobe Systems Inc |
ADBE |
Director |
2024-04-17 |
1,975 |
2024-04-17 |
4,672 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-MedsOf |
• – – |
2012-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,010 |
|
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-MedsOf |
• – – |
2012-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,936 |
|
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2015-07-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
12 |
61,005 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2013-10-21 |
5 |
GD |
$0.00 |
$0 |
D/D |
21 |
26,828 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President & CEO |
• • – |
2017-06-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
25 |
107,433 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2015-12-17 |
5 |
GD |
$0.00 |
$0 |
D/D |
72 |
60,933 |
0 |
- |
|
| ADBE |
Adobe Systems Inc |
Director |
– • – |
2018-09-24 |
4 |
B |
$261.43 |
$19,607 |
D/D |
75 |
1,252 |
2.39 |
- |
|
| ADBE |
Adobe Systems Inc |
Director |
– • – |
2018-12-20 |
4 |
B |
$216.58 |
$16,244 |
D/D |
75 |
1,327 |
2.39 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2014-04-29 |
5 |
GD |
$0.00 |
$0 |
D/D |
85 |
34,155 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2013-05-29 |
5 |
GD |
$0.00 |
$0 |
D/D |
92 |
26,849 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2015-03-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
183 |
61,017 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President & CEO |
• • – |
2017-05-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
357 |
107,076 |
0 |
- |
|
| ADBE |
Adobe Systems Inc |
Director |
– • – |
2022-04-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
615 |
3,939 |
0 |
- |
|
| ADBE |
Adobe Systems Inc |
Director |
– • – |
2023-04-20 |
4 |
OE |
$0.00 |
$0 |
I/I |
672 |
5,811 |
0 |
- |
|
| ADBE |
Adobe Systems Inc |
Director |
– • – |
2024-04-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
836 |
1,975 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2012-12-03 |
4 |
D |
$49.04 |
$42,420 |
D/D |
(865) |
18,767 |
0 |
- |
|
| ADBE |
Adobe Systems Inc |
Director |
– • – |
2021-04-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
924 |
3,324 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President, Chair, and CEO |
• • – |
2024-02-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
956 |
440,858 |
0 |
- |
|
| ADBE |
Adobe Systems Inc |
Director |
– • – |
2020-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,073 |
2,400 |
0 |
- |
|
| ADBE |
Adobe Systems Inc |
Director |
– • – |
2019-04-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,177 |
1,327 |
0 |
- |
|
| ADBE |
Adobe Systems Inc |
Director |
– • – |
2022-09-27 |
4 |
B |
$280.56 |
$336,672 |
D/D |
1,200 |
5,139 |
2.39 |
% |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2014-09-08 |
4 |
D |
$64.72 |
$87,566 |
D/D |
(1,353) |
34,240 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2014-09-08 |
4 |
OE |
$55.65 |
$83,976 |
D/D |
1,509 |
35,593 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
• – – |
2016-02-03 |
4 |
AS |
$76.73 |
$188,756 |
D/D |
(2,460) |
79,403 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President & CEO |
• • – |
2017-12-03 |
4 |
D |
$85.32 |
$221,917 |
D/D |
(2,601) |
107,458 |
0 |
- |
|
74 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
